These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16886192)

  • 1. Solubilization and dissolution of tamoxifen-hydroxybutenyl cyclodextrin complexes.
    Buchanan CM; Buchanan NL; Edgar KJ; Lambert JL; Posey-Dowty JD; Ramsey MG; Wempe MF
    J Pharm Sci; 2006 Oct; 95(10):2246-55. PubMed ID: 16886192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin.
    Klein S; Wempe MF; Zoeller T; Buchanan NL; Lambert JL; Ramsey MG; Edgar KJ; Buchanan CM
    J Pharm Pharmacol; 2009 Jan; 61(1):23-30. PubMed ID: 19126293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of raloxifene in male Wistar-Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin.
    Wempe MF; Wacher VJ; Ruble KM; Ramsey MG; Edgar KJ; Buchanan NL; Buchanan CM
    Int J Pharm; 2008 Jan; 346(1-2):25-37. PubMed ID: 17644287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-beta-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Malcolm MO; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Mar; 96(3):644-60. PubMed ID: 17083091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    Biomacromolecules; 2008 Jan; 9(1):305-13. PubMed ID: 18072746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of water-soluble hydroxybutenyl cyclomaltooligosaccharides (cyclodextrins).
    Buchanan CM; Alderson SR; Cleven CD; Dixon DW; Ivanyi R; Lambert JL; Lowman DW; Offerman RJ; Szejtli J; Szente L
    Carbohydr Res; 2002 Mar; 337(6):493-507. PubMed ID: 11890887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin.
    Tommasini S; Calabrò ML; Raneri D; Ficarra P; Ficarra R
    J Pharm Biomed Anal; 2004 Oct; 36(2):327-33. PubMed ID: 15496325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumichrome complexation by cyclodextrins: influence of pharmaceutical excipients.
    Lilletvedt M; Kristensen S; Tønnesen HH
    Pharmazie; 2010 Dec; 65(12):871-6. PubMed ID: 21284255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
    Yuvaraja K; Khanam J
    J Pharm Biomed Anal; 2014 Aug; 96():10-20. PubMed ID: 24705456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin-enhanced solubilization of pentachlorophenol in water.
    Hanna K; de Brauer Ch; Germain P
    J Environ Manage; 2004 May; 71(1):1-8. PubMed ID: 15084354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.
    Semalty A
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1255-72. PubMed ID: 24909802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):363-8. PubMed ID: 26687191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of organic salts on the cyclodextrin solubilization of drugs.
    Loftsson T; Matthíasson K; Másson M
    Int J Pharm; 2003 Aug; 262(1-2):101-7. PubMed ID: 12927392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
    Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When can cyclodextrins be considered for solubilization purposes?
    Rao VM; Stella VJ
    J Pharm Sci; 2003 May; 92(5):927-32. PubMed ID: 12712411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.